Open letter to the Secretary of State for International Trade on the UK-India negotiations

0

ABPI is one of 11 leading cross-industry business groups who have written to Anne-Marie Trevelyan about the UK-India talks

Right Honorable Anne-Marie Trevelyan MP
Secretary of State for International Trade
Old Admiralty Building, Place de l’Amirauté
London, SW1A 2DY
UK

August 11, 2022

Dear Secretary of State for International Trade,

As negotiations continue for an ambitious UK-India Free Trade Agreement, we, the undersigned organizations (representing a strong cross-section of major traders), urge the government and its negotiators to expect a meaningful and comprehensive trade deal, even if it means the self-imposed Diwali deadline is missed.

The Cabinet announced that, rather than launching a new policy or revisiting previously agreed positions, the government should focus on delivering the agenda it has already collectively agreed to. Negotiating until a balanced outcome is achieved, even if that means continuing after October, is fully in line with the government’s manifesto commitments.

A new UK-India Free Trade Agreement represents a unique opportunity to strengthen the already close economic ties between the two countries and set a new international standard for India’s trade deals.

It is the content of the agreement that matters to British companies, not the speed of the negotiations. We appreciate the efforts of the negotiators on both sides, who are working tirelessly, but the substance must come before any deadline.

We are committed to continuing to provide the UK Government with all necessary support to bring these negotiations to a successful conclusion.

Cordially,

Bar Council
Chartered Institute of Public Relations
Chemical Industries Association
City of London Corporation
Institute of Chartered Accountants in England and Wales
Law Society of England and Wales
MakeUK
Professional and Business Services Council (business side)
Society of Automobile Manufacturers and Traders
TechUK
The Association of the British Pharmaceutical Industry

Share.

Comments are closed.